Home » Topics » Regulatory » EMA

EMA
RSS

EMA issues encouraging scientific advice on phase III perifosine trial in colorectal cancer

July 1, 2010

AMAG and Takeda begin global registrational program of ferumoxytol

July 1, 2010

EMA's CHMP issues positive opinion for Pharming's Rhucin

June 29, 2010

CHMP recommends approval of vernakalant for atrial fibrillation

June 29, 2010

CHMP confirms previous negative opinion for ceftobiprole

June 29, 2010

CHMP recommends approval of Sycrest for bipolar disorder

June 29, 2010

CHMP recommends approval of Shire's VPRIV for type 1 GD

June 29, 2010

Pharmaxis reports on second phase III trial of Bronchitol in CF

June 23, 2010

EC grants orphan status to pralatrexate for cutaneous T-cell lymphoma

June 21, 2010

OBI-1 obtains positive opinion for orphan drug status in Europe

June 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...